 |
||||
| 2007 JASN IMPACT FACTOR 7.111 | HOME AUTHOR INFO EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP | |||
| CURRENT ISSUE | ARCHIVES | JASN Express | ONLINE SUBMISSION | |
|
||||
| 2007 JASN IMPACT FACTOR 7.111 | HOME AUTHOR INFO EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP | |||
| CURRENT ISSUE | ARCHIVES | JASN Express | ONLINE SUBMISSION | |
BASIC SCIENCE |
*Department of Internal Medicine, University of Heidelberg, Germany; Department of Nephrology, Endocrinology and Metabolic Diseases, Medical University of Silesia, Katowice, Poland; Department of Pathology, University of Heidelberg, Germany; and Department of Pathology, University of Erlangen-Nürnberg, Germany.
Correspondence to Prof. Dr. Kerstin Amann, Department of Pathology, Krankenhausstr. 8-10, D-91054 Erlangen, Germany. Phone: 0049-9131-8522291; Fax: 0049-9131-8522601;
ABSTRACT. Interventions to block the renin-angiotensin system (RAS) halt the progression of renal lesions in renal damage models. It has recently also been reported that established glomerulosclerosis can be reversed by pharmacologic blockade of the RAS. It was the aim of this study to confirm that high doses of angiotensin-converting enzyme (ACE) inhibitors reverse established glomerulosclerosis and to extend the findings by providing quantitative information on glomerular geometry, podocytes and other glomerular cells, renal vessels and tubulointerstitial tissue. Male Sprague Dawley rats were subjected to subtotal surgical renal ablation (SNX) (n = 27) or sham operation (n = 31) and fed using a pair-feeding protocol. Eight weeks after surgery, rats were either sacrificed or allocated to two arms: enalapril treatment (48 mg/kg body wt per day administered in the drinking fluid for 4 wk) or no treatment. Renal morphology was evaluated after 8 or 12 wk, respectively, by stereology in tissue fixed by pressure-controlled perfusion. Both systolic BP and albumin excretion rate were significantly higher in SNX compared with sham-operated controls. They were significantly reduced in SNX after delayed enalapril treatment. The glomerulosclerosis (GSI), tubulointerstitial (TII), and vascular (VI) damage indices were significantly higher in all SNX groups than in sham-operated controls. At the end of the experiment (12 wk after SNX) GSI, TII, and VI were significantly lower in SNX with delayed enalapril treatment (0.77 ± 0.18, 0.63 ± 0.19 and 0.43 ± 0.16, respectively) compared with untreated SNX (1.64 ± 0.14, 1.16 ± 0.34 and 0.67 ± 0.29, respectively). GSI, TII, and VI were also significantly lower in SNX with delayed enalapril treatment compared with SNX sacrificed without treatment 8 wk after SNX. The same was true for glomerular volume. The number of podocytes was not affected by SNX, but podocyte volume was increased. Both indices remained unaffected by treatment. The numbers of cells within the mesangium and endothelial cells per glomerulus were significantly lower in SNX after delayed enalapril treatment compared with untreated SNX. These results strongly suggest regression of preexisting lesions, i.e., glomerular, tubular, and vascular remodeling as well as reversal of glomerular hypertrophy by ACE inhibitor treatment. The study confirms that high-dose ACE inhibitor treatment causes partial reversal of glomerular as well as interstitial lesions in subtotally nephrectomized rats. E-mail: kerstin.amann@patho.imed.uni-erlangen.de
This article has been cited by other articles:
 |
|
 |
|
  G. Piecha, N. Koleganova, M.-L. Gross, A. Geldyyev, M. Adamczak, and E. Ritz Regression of glomerulosclerosis in subtotally nephrectomized rats: effects of monotherapy with losartan, spironolactone, and their combination Am J Physiol Renal Physiol, July 1, 2008; 295(1): F137 - F144. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Ruggenenti, E. Perticucci, P. Cravedi, V. Gambara, M. Costantini, S. K. Sharma, A. Perna, and G. Remuzzi Role of Remission Clinics in the Longitudinal Treatment of CKD J. Am. Soc. Nephrol., June 1, 2008; 19(6): 1213 - 1224. [Full Text] [PDF]
|
|
|
|
|
|
G. Piecha, G. Kokeny, K. Nakagawa, N. Koleganova, A. Geldyyev, I. Berger, E. Ritz, C. P. Schmitt, and M.-L. Gross Calcimimetic R-568 or calcitriol: equally beneficial on progression of renal damage in subtotally nephrectomized rats Am J Physiol Renal Physiol, April 1, 2008; 294(4): F748 - F757. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Boor, K. Sebekova, T. Ostendorf, and J. Floege Treatment targets in renal fibrosis Nephrol. Dial. Transplant., December 1, 2007; 22(12): 3391 - 3407. [Full Text] [PDF]
|
|
|
|
 |
|
 R. Martinelli, C. V. Santos, M. L Albuquerque, A. M Silva, and L. E. Rodrigues In vivo effect of enalapril on lysosomal compartment isolated from kidney and liver of rats Journal of Renin-Angiotensin-Aldosterone System, September 1, 2007; 8(3): 105 - 109. [Abstract] [PDF]
|
|
|
|
|
|
E. Podjarny, J. Bernheim, G. Hasdan, D. Karsh, G. Rashid, J. Green, B. Katz, and J. Bernheim Additive renoprotective effect of candesartan and tetrahydrobiopterin in rats after 5/6 nephrectomy Nephrol. Dial. Transplant., July 1, 2007; 22(7): 1864 - 1872. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. A. Griffin and A. K. Bidani Progression of Renal Disease: Renoprotective Specificity of Renin-Angiotensin System Blockade Clin. J. Am. Soc. Nephrol., September 1, 2006; 1(5): 1054 - 1065. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X.-B. Liang, L.-J. Ma, T. Naito, Y. Wang, M. Madaio, R. Zent, A. Pozzi, and A. B. Fogo Angiotensin Type 1 Receptor Blocker Restores Podocyte Potential to Promote Glomerular Endothelial Cell Growth J. Am. Soc. Nephrol., July 1, 2006; 17(7): 1886 - 1895. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. B. Fogo Progression versus regression of chronic kidney disease Nephrol. Dial. Transplant., February 1, 2006; 21(2): 281 - 284. [Full Text] [PDF]
|
|
|
|
 |
|
 J. Bolbrinker, S. Markovic, M. Wehland, W. B. W. H. Melenhorst, H. van Goor, and R. Kreutz Expression and Response to Angiotensin-Converting Enzyme Inhibition of Matrix Metalloproteinases 2 and 9 in Renal Glomerular Damage in Young Transgenic Rats with Renin-Dependent Hypertension J. Pharmacol. Exp. Ther., January 1, 2006; 316(1): 8 - 16. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Macconi, M. Bonomelli, A. Benigni, T. Plati, F. Sangalli, L. Longaretti, S. Conti, H. Kawachi, P. Hill, G. Remuzzi, et al. Pathophysiologic Implications of Reduced Podocyte Number in a Rat Model of Progressive Glomerular Injury Am. J. Pathol., January 1, 2006; 168(1): 42 - 54. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Wolf Zenon's paradox or how much to lower blood pressure for optimal renoprotection Nephrol. Dial. Transplant., November 1, 2005; 20(11): 2304 - 2307. [Full Text] [PDF]
|
|
|
|
|
|
G. Wolf 'As time goes by': angiotensin II-mediated transactivation of the EGF receptor comes of age Nephrol. Dial. Transplant., October 1, 2005; 20(10): 2050 - 2053. [Full Text] [PDF]
|
|
|
|
|
|
C. Chatziantoniou and J.-C. Dussaule Insights into the mechanisms of renal fibrosis: is it possible to achieve regression? Am J Physiol Renal Physiol, August 1, 2005; 289(2): F227 - F234. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L.-J. Ma, S. Nakamura, J. C. Aldigier, M. Rossini, H. Yang, X. Liang, I. Nakamura, C. Marcantoni, and A. B. Fogo Regression of Glomerulosclerosis with High-Dose Angiotensin Inhibition Is Linked to Decreased Plasminogen Activator Inhibitor-1 J. Am. Soc. Nephrol., April 1, 2005; 16(4): 966 - 976. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Remuzzi and A. Remuzzi Is Regression of Chronic Nephropathies a Therapeutic Target? J. Am. Soc. Nephrol., April 1, 2005; 16(4): 840 - 842. [Full Text] [PDF]
|
|
|
|
|
|
M. Adamczak, M.-L. Gross, K. Amann, and E. Ritz Reversal of Glomerular Lesions Involves Coordinated Restructuring of Glomerular Microvasculature J. Am. Soc. Nephrol., December 1, 2004; 15(12): 3063 - 3072. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Podjarny, G. Hasdan, J. Bernheim, G. Rashid, J. Green, Z. Korzets, and J. Bernheim Effect of chronic tetrahydrobiopterin supplementation on blood pressure and proteinuria in 5/6 nephrectomized rats Nephrol. Dial. Transplant., September 1, 2004; 19(9): 2223 - 2227. [Abstract] [Full Text] [PDF]
|
|
|
HOME
CURRENT ISSUE
ARCHIVES
JASN Express
ONLINE SUBMISSION
AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP |
Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673
